Q-omics provides the consensus-scored SSU72P1 profile across patient tissues and cancer cell-line models. SSU72P1 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, SSU72P1 is differentially expressed in 2, with the highest sampling consensus in COAD. Additionally, SSU72P1 RNA expression shows 4,450 significant pathway-activity associations, with the highest sampling consensus in UCEC. Together, these results highlight KIRC, COAD, and UCEC as cancer lineages where SSU72P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SSU72P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SSU72P1 survival associations across molecular data types. SSU72P1 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SSU72P1 RNA expression–survival associations across cancer types. High SSU72P1 expression shows unfavorable associations in KIRC, KICH, LIHC, TGCT and LUAD, but favorable associations in SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for SSU72P1 RNA expression.
This table summarizes SSU72P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for SSU72P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SSU72P1 shows higher tumor expression in COAD and LIHC. The COAD box plot shows higher SSU72P1 RNA expression in tumor versus normal tissue (log2 FC = +0.119, t-test p = .028).
This table shows molecular features associated with SSU72P1 in patient tissues and cancer cell lines. In patient samples, SSU72P1 shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set.
